跳至主要内容
临床试验/NCT00937456
NCT00937456已完成不适用

Open vs Laparoscopically-assisted Esophagectomy for Cancer: A Multicentric Phase III Prospective Randomized Controlled Trial

University Hospital, Lille22 个研究点 分布在 1 个国家目标入组 207 人开始时间: 2009年10月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
207
试验地点
22
主要终点
To decrease postoperative major 30-days morbidity from 45% in the open arm to 25% in the laparoscopically-assisted arm.

研究概览

简要总结

To compare laparoscopically-assisted gastric mobilization versus open gastric mobilization in Ivor-Lewis esophagectomy for esophageal cancer, with open thoracic approach in the 2 arms.

详细描述

Open Versus Laparoscopically-assisted Esophagectomy for Cancer

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Squamous cell or adenocarcinoma of the thoracic esophagus T1, T2, T3, N0-N1, M0, before any treatment
  • Middle or lower third esophageal carcinoma, junctional tumor Siewert type I
  • Patients who underwent or not neoadjuvant chemotherapy or chemoradiation
  • Tumor deemed to be resectable in a curative intent at the preoperative setting
  • Age less than 75 years old, OMS status 0, 1 or 2
  • Patient who can undergo one or the other surgical modality
  • Written informed consent form
  • Possible follow-up

排除标准

  • General criteria: PO2 ≤ 60 mmHg; PCO2 > 45 mmHg; FEV ≤ 1000 ml/sec
  • Hepatic cirrhosis
  • Recent myocardial infarction (in the previous 6 months) or progressive coronary disease
  • Distal arteritis (Leriche-Fontaine stage II upwards)
  • Concomitant cancer, other than subcarinal esophageal cancer
  • Disease-related factors
  • Invasion of subclavicular lymph nodes in a clinical examination or on biospy
  • Lymph nodes near the origin of the celiac artery with a diameter ≥ 1 cm on CT or that appear to be suspect on endoscopic ultrasound (to differentiate them from the paracardial or left gastric lymph nodes, which does not constitute an exclusion criterion)
  • Recurrent nerve palsy
  • Evidence of extension to the tracheobronchial tree
  • Signs of mediastinal invasion (vertebral contact, aortic contact ≥ 90°, or invasion of nonresectable neighboring organs such as the aorta, trachea, main bronchi, etc.)
  • Distant metastasis
  • Laparoscopy-related factors
  • Patient presenting a general contraindication to laparoscopy
  • A history of median or subcostal laparotomy

研究组 & 干预措施

Laparoscopically-assisted esophagectomy

Experimental

Laparoscopically-assisted esophagectomy: standard abdominal procedure of gastric mobilisation but through laparoscopic route. Right thoracotomy as usual.

干预措施: Laparoscopically-assisted esophagectomy (Procedure)

Open esophagectomy

Active Comparator

Conventional open esophagectomy: Esophagectomy with extended 2-field lymphadenectomy through laparotomy and right thoracotomy (Ivor-Lewis standard procedure)

干预措施: Laparoscopically-assisted esophagectomy (Procedure)

结局指标

主要结局

To decrease postoperative major 30-days morbidity from 45% in the open arm to 25% in the laparoscopically-assisted arm.

时间窗: 30 days

次要结局

  • quality of life(2 years)
  • disease free survival(2 years)
  • economical interest of the surgical technique apprehended through a hospital point of view(6 months)
  • overall morbidity(30 days)
  • overall survival(2 years)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验

Open Versus Laparoscopically-assisted Esophagectomy... | 临床试验